Vladimir Ivanov
4PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 24, 2026
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy.Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos
|Jan 11, 2026
Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial.Bin Jiang, Jian Li, Ligen Liu
|Nov 21, 2025
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy.Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos
|Sep 16, 2022
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos
Pageof 1
Frequent Collaborators
4 joint publications
Jianxiang Wang
3 joint publications
Andrew H Wei
3 joint publications
Panayiotis Panayiotidis
3 joint publications
Pau Montesinos
3 joint publications
Yan Sun
3 joint publications
Courtney D DiNardo
2 joint publications
Tara L Lin
2 joint publications
Stephen B Ting
2 joint publications
Stephen A Strickland
2 joint publications
Michael R Savona
